Genistein, a selective protein tyrosine kinase inhibitor, inhibits interleukin-2 and leukotriene B4 production from human mononuclear cells
Authors:
- 1 June 1991
- journal article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 59 (3) , 379-387
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- T Cell Antigen Receptor-Mediated Activation of Phospholipase C Requires Tyrosine PhosphorylationScience, 1990
- Tyrosine protein kinase activity in normal and leukaemic human blood cellsBritish Journal of Haematology, 1989
- Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological EffectsScience, 1987
- Stimulation of interleukin 2 and interferon gamma production by leukotriene B4 in human lymphocyte culturesProstaglandins, Leukotrienes and Medicine, 1986
- High tyrosine-specific protein kinase activity in normal human peripheral blood lymphocytesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1985
- Higher tyrosine protein kinase activity in resting lymphocytes than in proliferating normal or leukaemic blood cellsBiochemical and Biophysical Research Communications, 1984
- Stimulation of tyrosine phosphorylation in lectin treated human lymphocytesBiochemical and Biophysical Research Communications, 1984
- Control of polyclonal immunoglobulin production from human lymphocytes by leukotrienes; leukotriene B4 induces an OKT8(+), radiosensitive suppressor cell from resting, human OKT8(-) T cells.Journal of Clinical Investigation, 1984
- The influence of lipoxygenase inhibitors on the in vitro production of human leukocytic pyrogen and lymphocyte activating factor (interleukin-1)International Journal of Immunopharmacology, 1984
- Leukotriene B4 induces human suppressor lymphocytesBiochemical and Biophysical Research Communications, 1982